Arcutis Biotherapeutics, Inc. (ARQT) Ownership

$16.74

$0.15 (-0.89%)
Last update: 04:00 PM EST
Day's range
$16.54
Day's range
$17.29

Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2025 11.42 M $178.66 M   0.21% 9.06%
JENNISON ASSOCIATES LLC 05/05/2025 11.36 M $177.68 M   -7.93% 9.01%
RUBRIC CAPITAL MANAGEMENT LP 05/14/2025 10.97 M $171.52 M   0.00% 8.70%
BLACKROCK, INC. 05/02/2025 8.89 M $139.08 M   -2.80% 7.06%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 8.79 M $137.40 M   0.00% 6.97%
VANGUARD GROUP INC 05/09/2025 6.82 M $106.63 M   5.86% 5.41%
POLAR CAPITAL HOLDINGS PLC 05/15/2025 6.71 M $104.89 M   -9.09% 5.32%
STATE STREET CORP 05/15/2025 4.47 M $69.98 M   -9.63% 3.55%
GILDER GAGNON HOWE & CO LLC 05/15/2025 4.10 M $64.06 M   4.95% 3.25%
MORGAN STANLEY 05/15/2025 3.84 M $60.03 M   -9.55% 3.05%
UBS GROUP AG 05/13/2025 2.92 M $45.67 M   4.68% 2.32%
FRANKLIN RESOURCES INC 05/13/2025 2.76 M $43.19 M   -16.55% 2.19%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.55 M $39.84 M   3.00% 2.02%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 05/14/2025 2.12 M $33.16 M   0.00% 1.68%
D. E. SHAW & CO., INC. 05/15/2025 1.99 M $31.12 M   -20.85% 1.58%
ENSIGN PEAK ADVISORS, INC 05/14/2025 1.99 M $31.10 M   -16.25% 1.58%
AMERICAN CENTURY COMPANIES INC 05/13/2025 1.65 M $25.84 M   1.30% 1.31%
GW&K INVESTMENT MANAGEMENT, LLC 05/05/2025 1.51 M $23.65 M   -2.06% 1.20%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2025 1.47 M $22.92 M   100.00% 1.16%
CORMORANT ASSET MANAGEMENT, LP 05/15/2025 1.35 M $21.11 M   -26.03% 1.07%
INVESCO LTD. 05/12/2025 1.33 M $20.78 M   17.95% 1.05%
GOLDMAN SACHS GROUP INC 06/27/2025 1.10 M $17.26 M   -15.52% 0.88%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 1.09 M $17.09 M   -0.37% 0.87%
CANDRIAM S.C.A. 05/14/2025 1.04 M $16.20 M   -0.63% 0.82%
NORTHERN TRUST CORP 05/13/2025 976.07 K $15.27 M   -1.51% 0.77%
CERCANO MANAGEMENT LLC 05/13/2025 928.70 K $14.52 M   -26.02% 0.74%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 860.77 K $13.46 M   -2.05% 0.68%
TEJARA CAPITAL LTD 05/13/2025 846.22 K $13.23 M   -4.58% 0.67%
POINT72 ASSET MANAGEMENT, L.P. 07/21/2025 830.48 K $12.99 M   -52.64% 0.66%
05/12/2025 815.82 K $12.76 M   100.00% 0.65%
FEDERATED HERMES, INC. 05/08/2025 737.56 K $11.54 M   49.63% 0.59%
SIMPLIFY ASSET MANAGEMENT INC. 05/13/2025 660.56 K $10.33 M   -11.01% 0.52%
PRUDENTIAL FINANCIAL INC 05/13/2025 593.20 K $9.28 M   0.11% 0.47%
ABRDN PLC 05/13/2025 587.54 K $9.19 M   21.88% 0.47%
JPMORGAN CHASE & CO 05/12/2025 543.38 K $8.50 M   -52.40% 0.43%
FISHMAN JAY A LTD/MI 04/22/2025 533.15 K $8.34 M   -0.61% 0.42%
BANK OF AMERICA CORP /DE/ 05/15/2025 514.95 K $8.05 M   -4.01% 0.41%
MILLENNIUM MANAGEMENT LLC 05/15/2025 473.63 K $7.41 M   -79.50% 0.38%
FIRST TRUST ADVISORS LP 05/14/2025 440.19 K $6.88 M   67.28% 0.35%
STEMPOINT CAPITAL LP 05/15/2025 440.07 K $6.88 M   -12.16% 0.35%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 427.43 K $6.69 M   314.42% 0.34%
WOODLINE PARTNERS LP 05/15/2025 410.00 K $6.41 M   100.00% 0.33%
DEUTSCHE BANK AG\ 05/09/2025 381.36 K $5.96 M   -1.59% 0.30%
LAZARD ASSET MANAGEMENT LLC 05/15/2025 374.08 K $5.85 M   -3.66% 0.30%
PRIVIUM FUND MANAGEMENT B.V. 05/09/2025 325.71 K $5.09 M   0.00% 0.26%
PDT PARTNERS, LLC 05/15/2025 317.47 K $4.97 M   -0.70% 0.25%
CITADEL ADVISORS LLC 05/15/2025 310.08 K $4.85 M   247.74% 0.25%
CITIGROUP INC 05/12/2025 301.55 K $4.72 M   -7.86% 0.24%
BANK OF NEW YORK MELLON CORP 04/29/2025 300.03 K $4.69 M   -1.63% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 292.10 K $4.57 M   20.95% 0.23%

Arcutis Biotherapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 184 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:

SUVRETTA CAPITAL MANAGEMENT, LLC: 11.54 M

JENNISON ASSOCIATES LLC: 11.11 M

Frazier Life Sciences Management, L.P.: 9.87 M

BlackRock, Inc.: 8.53 M

Polar Capital Holdings Plc: 5.01 M

GILDER GAGNON HOWE & CO LLC: 4.16 M

99.19% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 87.44 M shares in the last 24 months. This purchase volume represents approximately $1.46 B in transactions.